Current Month 2011
Article Features
  African-American Breast Cancer Survivors Face Higher Risk of Heart Failure
Better Estrogen Testing Methods Needed to Improve Patient Care
Compounds Found That Alter Cell Signaling, Could Lead to New Breast Cancer Treatments
Detecting Circulating Tumor Cells
False-Positive Mammography Results Cause Significant Long-Term Psychological Harm
Gene Profile May Help Identify Risk for Hormone-Sensitive, Hormone-Insensitive Breast Cancer
Genetic Risk Strategies Needed for Young, Black, Female Breast Cancer Patients
High-Fat Dairy Products Linked to Poorer Breast Cancer Survival
Hormone-Therapy-Related Breast Cancers Cells Could Be Attacked By New Therapies
Nearly 1 in 4 Women Newly Diagnosed with Breast Cancer Suffer Post-Traumatic Stress Disorder
Neighborhood Poverty and Health Insurance Figure in Late-Stage Breast Cancer Diagnosis
New Chemo Drug Gentler on Fertility, Tougher on Cancer
New DNA Sequences Hone In On Breast, Ovarian Cancer Risk
New Imaging Agent Enables Better Cancer Detection, More Accurate Staging
Physical Activity Does Not Protect Against In Situ Breast Cancer
Promising New Drug Treats and Protects Against Radiotherapy-Associated Oral Mucositis
Round or 'Shaped,' Implants Yield Good Results in Breast Reconstruction
Study Examines Outcomes of Screening Mammography for Age, Breast Density, Hormone Therapy
Study Examines Outcomes of Screening Mammography for Age, Breast Density, Hormone Therapy
Study Shows Key Enzyme Missing From Aggressive Form of Breast Cancer
The Right Dose for Oncology
Trackable Drug-Filled Nanoparticles – A Potential Weapon Against Cancer
Unique Study Reveals Genetic ‘Spelling Mistakes’ That Increase Risk of Common Cancers


Nearly 1 in 4 Women Newly Diagnosed with Breast Cancer Suffer Post-Traumatic Stress Disorder

A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, has found that nearly one in four women (23 percent) newly diagnosed with breast cancer reported symptoms consistent with post-traumatic stress disorder (PTSD) shortly after diagnosis, with increased risk among black and Asian women. The research was published in the Journal of the National Cancer Institute.

"This study is one of the first to evaluate the course of PTSD after a diagnosis of breast cancer," said lead author Alfred I. Neugut, MD, PhD, the Myron M. Studner Professor of Cancer Research, professor of medicine and epidemiology, at Columbia University's College of Physicians & Surgeons and Mailman School of Public Health, and a member of the HICCC.

"We analyzed interview responses from more than 1,100 women," said Neugut. "During the first two to three months after diagnosis, nearly a quarter of them met the criteria for PTSD, although the symptoms declined over the next three months. Younger women were more likely to develop symptoms of PTSD, and data suggest Asian and black women are at a more than 50 percent higher risk than white women."

The 1,139 research participants were part of the Breast Cancer Quality of Care Study (BQUAL). Between 2006 and 2010, women with newly diagnosed breast cancer, stages I to III, over the age of 20 were recruited from NewYork-Presbyterian/Columbia University Medical Center and Mount Sinai School of Medicine in New York City; the Henry Ford Health System in Detroit; and Kaiser-Permanente in Northern California. Each participant completed three phone interviews. The first was two to three months after diagnosis and before the third chemotherapy cycle, if the patient was receiving chemotherapy. The second interview was four months after diagnosis, and the third was six months after diagnosis.



 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon